Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection

Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection

<p><strong>Background</strong> A synergistic effect of combination therapy with favipiravir and oseltamivir has been reported in preclinical models of influenza. However, no data are available on the clinical effectiveness of combination therapy in severe influenza.</p> <...

Detaylı Bibliyografya
Asıl Yazarlar:	Wang, Y, Fan, G, Salam, A, Horby, P, Hayden, F, Chen, C, Pan, J, Zheng, J, Lu, B, Guo, L, Wang, C, Cao, B, Cap-China Network
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Oxford University Press 2019

Benzer Materyaller

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
Yazar:: Wang, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
Yazar:: Parvaiz A Koul, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Does Oseltamivir Really Reduce Complications of Influenza?
Yazar:: Del Mar, C, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
Yazar:: Chairat, K, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023
Yazar:: Mihai Maria Elena, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Ode to Oseltamivir and Amantadine?
Yazar:: JM Conly, ve diğerleri
Baskı/Yayın Bilgisi: (2006-01-01)

Exacerbation of neuropsychiatric symptoms in an adult male with influenza A virus treated with oseltamivir
Yazar:: Masa Scott, PharmD, BCPS, BCPP, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Impact of Oseltamivir and Diabetes Development
Yazar:: Bor-Show Tzang, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care
Yazar:: Lee, J, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Evaluation of the efficacy of triazavirin versus oseltamivir in management of COVID-19
Yazar:: Sara Samir Mohamed Elmenshawy, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.
Yazar:: Anthony C Marriott, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Cost-Effectiveness of Baloxavir Marboxil Versus Oseltamivir or no Treatment for the Management of Influenza in the United States
Yazar:: Svenn Alexander Kommandantvold, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Acute Cheilitis Associated with Oseltamivir after Influenzae A Infection
Yazar:: Koji Yokoyama, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Impact of oseltamivir on the risk of cancer
Yazar:: Pei-Hua Chuang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
Yazar:: A.B. Ivanyuk, ve diğerleri
Baskı/Yayın Bilgisi: (2008-01-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
Yazar:: A.B. Ivanyuk, ve diğerleri
Baskı/Yayın Bilgisi: (2008-01-01)

Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.
Yazar:: Instiaty, I, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
Yazar:: Seo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.
Yazar:: Le, Q, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza
Yazar:: Mai, L, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial
Yazar:: Butler, CC, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Oseltamivir resistance in influenza A (H5N1) infection - Reply
Yazar:: Jong, d, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
Yazar:: Hurt, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial
Yazar:: A. V. Averyanov, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

OSELTAMIVIR IN PEDIATRIC PRACTICES (WORLD'S APPLICATION EXPERIENCE)
Yazar:: A.S. Kolbin, ve diğerleri
Baskı/Yayın Bilgisi: (2008-11-01)

OSELTAMIVIR IN PEDIATRIC PRACTICES (WORLD'S APPLICATION EXPERIENCE)
Yazar:: A.S. Kolbin, ve diğerleri
Baskı/Yayın Bilgisi: (2008-11-01)

Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
Yazar:: Wattanagoon, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Efficacy and safety of intravenous peramivir versus oral oseltamivir in the treatment of influenza in children: A meta-analysis
Yazar:: Jie Yuan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Effectiveness of Antiviral Treatment with Intravenous Peramivir and Oral Oseltamivir for Seasonal Influenza in Children
Yazar:: Young-hoon Byun, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Evaluation of the Efficacy of Riamilovir and Oseltamivir Combination on the Experimental Model of Mice Influenza Infection
Yazar:: I. N. Falynskova, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Oseltamivir resistance during treatment of influenza A (H5N1) infection.
Yazar:: Jong, d, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

EFFICIENCY AND SAFETY OF NEURAMINIDASE INHIBITOR OSELTAMIVIR FOR CHILDREN
Yazar:: A.S. Darmanyan
Baskı/Yayın Bilgisi: (2007-10-01)

OSELTAMIVIR IN FLU TREATMENT AND PREVENTION AMONG CHILDREN
Yazar:: T.V. Kulichenko, ve diğerleri
Baskı/Yayın Bilgisi: (2007-12-01)

OSELTAMIVIR IN FLU TREATMENT AND PREVENTION AMONG CHILDREN
Yazar:: T.V. Kulichenko, ve diğerleri
Baskı/Yayın Bilgisi: (2007-12-01)

EFFICIENCY AND SAFETY OF NEURAMINIDASE INHIBITOR OSELTAMIVIR FOR CHILDREN
Yazar:: A.S. Darmanyan
Baskı/Yayın Bilgisi: (2007-10-01)

Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir
Yazar:: Wouter J. Meijer, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
Yazar:: Jefferson, T, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Importance of collection tube during clinical studies of oseltamivir.
Yazar:: Lindegardh, N, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Prescription of Antibiotics Among Patients Receiving Oseltamivir with an Influenza Related Diagnosis Over Three Influenza Seasons
Yazar:: Mine Durusu Tanriover, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Epidemiological, clinical characteristics and the association between influenza vaccination, oseltamivir treatment, and complications in children with seasonal influenza
Yazar:: Manh Cuong Nguyen, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)